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Abstract
Objective—Prehospital provider assessment of the use of anticoagulant or antiplatelet 
medications in older adults with head trauma is important. These patients are at increased risk for 
traumatic intracranial hemorrhage and therefore field triage guidelines recommend transporting 
these patients to centers capable of rapid evaluation and treatment. Our objective was to evaluate 
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EMS ascertainment of anticoagulant and antiplatelet medication use in older adults with head 
trauma.
Methods—A retrospective study of older adults with head trauma was conducted throughout 
Sacramento County. All 5 transporting EMS agencies and all 11 hospitals in the county were 
included in the study, which ran from January 2012 to December 2012. Patients ≥55 years who 
were transported to a hospital by EMS after head trauma were included. We excluded patients 
transferred between two facilities, patients with penetrating head trauma, prisoners, and patients 
with unmatched hospital data. Anticoagulant and antiplatelet use were categorized as: warfarin, 
direct oral anticoagulants (DOAC; dabigatran, rivaroxaban, and apixaban), aspirin, and other 
antiplatelet agents (e.g., clopidogrel, ticagrelor). We calculated the percent agreement and kappa 
statistic for binary variables between EMS and emergency department (ED)/hospital providers. A 
kappa statistic ≥0.60 was considered acceptable agreement.
Results—After excluding 174 (7.6%) patients, 2,110 patients were included for analysis; median 
age was 73 years (interquartile range 62–85 years) and 1,259 (60%) were male. Per ED/hospital 
providers, the use of any anticoagulant or antiplatelet agent was identified in 595 (28.2%) patients. 
Kappa statistics between EMS and ED/hospital providers for the specific agents were: 0.76 (95% 
CI 0.71–0.82) for warfarin, 0.45 (95% CI 0.19–0.71) for DOAC agents, 0.33 (95% CI 0.28–0.39) 
for aspirin, and 0.51 (95% CI 0.42–0.60) for other antiplatelet agents.
Conclusions—The use of antiplatelet or anticoagulant medications in older adults who are 
transported by EMS for head trauma is common. EMS and ED/hospital providers have acceptable 
agreement with preinjury warfarin use but not with DOAC, aspirin, and other antiplatelet use.
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BACKGROUND
Traumatic brain injury (TBI) accounts for an estimated 2.2 million emergency department 
(ED) visits, 280,000 hospitalizations and more than 50,000 deaths in the US at an estimated 
cost of $60 billion annually.1,2 With an aging population, older adults represent an 
increasing proportion of TBI patients treated at hospitals.3 Older adults have higher 
morbidity and mortality after TBI than younger patients due to anatomical differences, co-
morbidities, and more frequent use of anticoagulant and antiplatelet medications.1,3–5 The 
concurrent use of these medications in the setting of head trauma is especially problematic, 
increasing the risk for traumatic intracranial hemorrhage (tICH) and post-traumatic 
disability and death.6–8 Rapid diagnosis of tICH with cranial computed tomography (CT) is 
critical to determine the need for reversal of anticoagulant and antiplatelet effects with 
medications and blood products. Patients who have a delay in reversal have increased 
morbidity and mortality.9 In patients on warfarin requiring immediate neurosurgical 
intervention, rapid and efficacious reversal to an appropriate international normalized ratio 
(INR) level is essential as INR levels >1.25 increase postoperative mortality.10–12
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Accuracy of medication history in patients with preinjury anticoagulant or antiplatelet use 
and head trauma is crucial. Clinicians who are unaware that their patient is taking one of 
these medications may not obtain appropriate diagnostic imaging.13,14 Recommendations 
for cranial CT imaging after head trauma is much more liberal in anticoagulated patients 
compared to patients not on these medications.13,16 Many of these patients are initially well-
appearing and have low impact mechanisms of injury such as ground level falls, but have 
significant tICH requiring neurosurgical interventions and specialized critical care.17–20 
Older adults have low trauma center utilization but a high rate of interfacility transfers.21 In 
the prehospital setting, however, a number of barriers exist to accurate medication 
ascertainment including the acuity of the clinical presentation, limited access to prior 
medical records and medication lists, limited availability of family or translators, and 
unfamiliarity with medications by patients and their families. In addition, prehospital 
providers may be unaware of the names and uses of some of the newer anticoagulant or 
antiplatelet medications. Older adults with head trauma are particularly prone to these 
barriers, and they often have inaccurate and delayed medication reconciliation.22
Our objective for this study was to evaluate emergency medical services (EMS) medication 
ascertainment of preinjury anticoagulant and antiplatelet use in older adults with head 




This was a countywide, retrospective study at 5 EMS agencies and 11 hospitals. The study 
was approved by the UC Davis Institutional Review Board, the Dignity Health Sacramento-
Sierra Regional Institutional Review Board, the Kaiser Permanente Northern California 
Institutional Review Board, and the Sutter Health Central Area Institutional Review 
Committee.
Study Setting and Subjects
This study was conducted primarily in Sacramento County, which encompasses 994 square 
miles and has a resident population of 1,445,327 (2010 census). Sacramento County is 
served by 5 advanced life support EMS agencies that respond to all 9-1-1 medical 
emergencies. Over 2,400 EMS personnel are certified or accredited by the Sacramento 
County EMS Agency, including approximately 1,050 Paramedics and 1,400 Emergency 
Medical Technicians. The county has 9 general acute care hospitals and access to 2 
additional hospitals in the adjacent county. We included these two out-of-county acute care 
hospitals since Sacramento County EMS agencies routinely transport patients to these two 
hospitals. Cumulatively, these hospitals have a capacity of approximately 240 ED beds and 
3,400 total staffed in-patient beds. One hospital is a Level I adult trauma center and 3 are 
Level II adult trauma centers. In 2011, there were 3,345 major trauma victims admitted to 
the 4 designated trauma centers from incidents within Sacramento County.
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We included patients 55 years and older with head trauma who were transported to a 
hospital by EMS from January 1, 2012 to December 31, 2012. The age cutoff of 55 years 
was chosen based on recommendations of the National Expert Panel on Field Triage, 
2011.18 The risk for death after injury increases after age 55.18 The patient cohort was 
identified using billing data of the EMS agencies and the International Classification of 
Diseases, 9th revision, Clinical Modification (ICD-9-CM) diagnosis codes 959.01 (head 
injury unspecified) or 959.09 (injury of face and neck). Other head injury ICD-9 diagnostic 
codes were not used (e.g., 851 to 854 [traumatic intracranial hemorrhage]) as these codes 
require CT imaging for appropriate diagnosis. We excluded patients transferred by EMS 
from another receiving facility (interfacility transport), patients with penetrating head 
trauma, prisoners, and patients with unmatched hospital data.
Study Protocol and Measurements
All EMS agencies used similar prehospital patient care report (PCR) forms that included 
transport information, patient demographics, medical history, history of present illness, vital 
signs, physical examination findings, treatments, and assessments. Three of the EMS 
agencies used paper PCR forms and two of the agencies used electronic PCR forms. All 
medications were written or typed in.
A trained research coordinator abstracted the following data from EMS charts: patient 
identifiers (name, date of birth), transport characteristics (date of transport, EMS agency, 
level of transport, level of EMS provider, receiving hospital), antiplatelet and anticoagulant 
use in the past week (listed anywhere in the EMS chart), mechanism of injury, and clinical 
characteristics (initial Glasgow Coma Scale [GCS] score, reported dementia, reported 
intoxication). Anticoagulants included warfarin or direct oral anticoagulants (DOAC; 
dabigatran, rivaroxaban or apixaban). Antiplatelets included aspirin or other antiplatelet 
agents (clopidogrel, ticlodipine, prasugrel, dipyridamole, cilostazol, and ticagrelor).
Eligible EMS patient transports were linked to ED and hospital records using patient 
identifiers (name, date of birth, and date of transport). For the linked hospital visit, we 
reviewed ED and hospital electronic records including ED physician notes, hospital 
admission and discharge physician notes, and medication reconciliation lists and abstracted 
the following data: patient demographics (age, sex, ethnicity, race), antiplatelet and 
anticoagulant use, and INR levels.
Data Analysis
We formatted the data and recoded the variables using STATA 13.1 statistical software 
(STATA Corp, College Station, TX). Descriptive statistics were used to characterize the 
study population overall and within each indication category. Non-normal interval data were 
reported with medians and interquartile ranges.
For each anticoagulant and antiplatelet category (warfarin, DOAC, aspirin, and other 
antiplatelet agent) we calculated the percent present per EMS, the overall agreement, the 
percent specific agreement within each response option, and the kappa statistic (with 95% 
confidence intervals [CI]) using normal approximation methods.23 We considered a kappa 
statistic of 0.60 or higher to have acceptable agreement.24,25
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We conducted three sensitivity analyses. First, we compared EMS medication ascertainment 
of preinjury warfarin use to initial elevated INR levels (greater than 1.2) because the use of 
ED and hospital provider medication ascertainment may not be accurate as a reference 
standard. The INR level is an objective reference standard for warfarin use, but its use is 
limited in warfarin patients with subtherapeutic levels, patients who did not have an INR 
level obtained, and patients with elevated INR levels due to other factor deficiencies such as 
chronic liver disease rather than warfarin use. Second, we explored differences in medication 
ascertainment between different agencies by stratifying the warfarin, aspirin, and other 
antiplatelet agent groups by EMS agency and generated a plot of the kappa statistics with 
CIs. Third, we stratified EMS and ED/hospital agreement for preinjury warfarin use by level 
of transport (Advanced Life Support [ALS] vs. Basic Life Support [BLS]) and level of EMS 
provider (paramedic vs. non-paramedic) to evaluate for differences in level of training on 
medication ascertainment. For the 2nd and 3rd sensitivity analyses, we did not include the 
kappa statistics for the DOAC group due to the small number of patients with preinjury 
DOAC use during the study period.
RESULTS
Characteristics of the Subjects
We excluded 174 (7.6%) patients; 173 for unmatched hospital data and 1 with penetrating 
head trauma. Thus 2,110 patients were included for analysis. The median age was 73 years 
(interquartile range 62–85 years) and 1,259 (60%) were male. The most common 
mechanism of injury was fall from standing height or less (68%). The majority of patients 
had an initial GCS score by EMS of 15 (81%). Complete patient characteristics are reported 
in Table 1. The range of enrolled transports by EMS agency was 104 to 952 transports. 
Complete EMS provider characteristics are reported in Table 2.
Main Results
EMS providers recorded the use of any anticoagulant or antiplatelet medication in 349 
patients (16.5%). Warfarin use was recorded in 123 patients (5.8%), direct oral anticoagulant 
use in 7 patients (0.33%), aspirin use in 184 patients (8.7%), and other antiplatelet use in 59 
patients (2.8%). ED and hospital providers recorded the use of any anticoagulant or 
antiplatelet medication use in 595 patients (28.2%). Warfarin use was identified in 168 
patients (8.0%), direct oral anticoagulant use in 15 patients (0.71%), aspirin use in 372 
patients (17.6%), and 115 patients (5.5%) with other antiplatelet agent use. Overall 
agreement for any anticoagulant or antiplatelet medication use between EMS providers and 
ED and hospital providers was 90.5% with a kappa statistic of 0.45 (95% CI 0.41 to 0.49).
Only warfarin use (kappa 0.76) had acceptable agreement between EMS and ED/hospital 
providers while DOAC (kappa 0.45), aspirin (kappa 0.33), and other antiplatelet use (kappa 
0.51) did not meet our acceptable agreement threshold (kappa 0.60 or higher). Percent 
agreement and the kappa statistic for each subgroup of preinjury anticoagulant and 
antiplatelet use are reported in Table 3 and eTable 1 (Online Supplement).
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When an elevated INR (>1.2) was used as the reference standard for warfarin use, EMS 
providers had an overall percent agreement of 95.4% (positive agreement of 70.8%, negative 
agreement of 97.5%) and a kappa statistic of 0.68 (95% CI 0.62–0.74).
As demonstrated in Figure 1, the differences in agreement between warfarin and the other 
anticoagulant and antiplatelet agents were overall consistent within each EMS agency. 
Stratifying agreement by level of transport (ALS vs. BLS) suggested no difference in 
agreement between ALS and BLS transport (Figure 2, Panel A). However, stratifying by 
provider level (paramedic vs. non-paramedic) suggested a higher level of agreement with 
warfarin and aspirin use for paramedics compared to non-paramedics but no difference with 
other antiplatelet agents (Figure 2, Panel B). Complete agreement measurements presented 
in eTable 2 (Online Supplement).
DISCUSSION
Our study compared EMS to ED/hospital medication ascertainment of preinjury 
anticoagulant and antiplatelet use in older adults with head trauma. Our study included 1 
year of data from 5 EMS agencies and 11 receiving hospitals which accounted for the entire 
county’s 9-1-1 volume. The results of our study demonstrated two key findings. First, 
preinjury use of any antiplatelet or anticoagulant medication in older adults with head 
trauma was common – ED and hospital providers recorded that over 28% of patients were 
taking these medications. Second, only EMS medication ascertainment for preinjury 
warfarin use had an acceptable level of agreement with ED and hospital providers. 
Medication ascertainment for DOAC, aspirin, and other antiplatelet agent use had kappa 
statistics less than 0.60.
For EMS providers, obtaining an accurate medication history in patients with preinjury 
anticoagulant or antiplatelet use in the setting of head trauma is important. Older adults with 
preinjury anticoagulant or antiplatelet use are often initially well-appearing and have low 
impact mechanisms of injury (e.g., ground level falls) and thus do not routinely meet 
physiological, anatomical, or mechanism of injury criteria for field triage to a trauma 
center.17,18 However, these patients not infrequently have life-threatening tICH requiring 
emergent neurosurgical interventions and specialized critical care.19,20 The most recent field 
triage guidelines (2011) were modified to highlight the risk for rapid neurological 
deterioration in older adults with preinjury anticoagulant or antiplatelet use.18 Step four of 
these triage guidelines include the statement that patients with head trauma and either 
anticoagulant use or bleeding disorders are at high risk for rapid deterioration and EMS 
providers should consider transporting these patients to a trauma center.18
To our knowledge, this is the first study that evaluated EMS medication ascertainment of 
preinjury anticoagulant and antiplatelet use across a broad cohort of older adults with head 
trauma. The characteristics of our patient population were similar to prior studies of older 
adults with head trauma – the majority of patients presented to the ED after a ground level 
fall and with a normal mental status.14,26,27 Evans et al reported 60% of older adults 
presenting to the ED after a fall had preinjury use of anticoagulant or antiplatelet agents.28 
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However, the study included only patients triaged to the trauma resuscitation room and thus 
these patients more likely to be severely injured compared to our study. We identified one 
prior study that compared prehospital and ED medication reconciliation.29 Damlien et al 
found a 62% rate of clinically relevant medication discrepancies between prehospital and 
ED medication reconciliation. Age 60 years or older was an independent risk factor for 
having a clinically relevant medication discrepancy.
Our results suggest that prehospital medication ascertainment is better in patients with 
preinjury warfarin use than in patients with preinjury aspirin or other antiplatelet agents use. 
This may be due to EMS providers having greater awareness of the bleeding issues from 
warfarin and being more vigilant in identifying preinjury warfarin use than antiplatelet 
agents. Many head injury guidelines highlight the risk of intracranial bleeding in patients 
with warfarin use but they do not consider antiplatelet agents an indication for cranial 
imaging.13,15,16 Preinjury clopidogrel use in the setting of blunt head trauma, however, has 
been shown to have a higher risk for tICH than preinjury warfarin use.14 The higher level of 
agreement with warfarin compared to aspirin or other antiplatelet agents may also be due to 
patients reporting warfarin use to prehospital providers more accurately than reporting 
antiplatelet use. Older adults are particularly at risk for providing inaccurate medication 
histories.30 In addition, frequent INR checks in patients taking warfarin and their perceived 
risks of bleeding may make patients more aware of warfarin use than antiplatelet use.31
The threshold of a kappa statistic ≥0.60 for acceptable interrater agreement is based on 
precedent.24,25 Different thresholds of acceptability (e.g., kappa statistic ≥ 0.50) or use of 
the lower bound of the 95% confidence interval of the kappa statistic (≥ 0.40) have also been 
used.32–34 Several instances where the percent agreement was high (>80%) but the kappa 
statistic was fair or moderate (0.21 to 0.60) occurred due to what is known as the “kappa 
paradox”.35 In situations where the prevalence is very low or very high, the resulting kappa 
statistic may not fully reflect the reliability of the measure, necessitating the use of other 
measures such as percent agreement.36 The kappa paradox is particularly true for the 
evaluation of DOAC use. Due to the small number of patients taking DOAC agents at the 
time of our study, the measures of agreement for DOAC use has wide confidence intervals. 
Our study included patients from 2012, thus many of the DOAC agents were very new to the 
market (dabigatran [2010], rivaroxaban [2011] and apixaban [2012] for nonvalvular atrial 
fibrillation; rivaroxaban for venous thromboembolism prophylaxis [2011; knee or hip 
surgery] and treatment [2012]). With increasing use of the DOAC agents, future studies 
should be directed at evaluating prehospital medication ascertainment of these 
medications.37
Given the importance of identifying all medications that increase the risk for tICH, future 
work may include using enhanced electronic patient care records such as drop down lists or 
disease specific alerts.38 Our sensitivity analysis stratifying by level of EMS provider 
suggested a higher level of agreement with warfarin and aspirin use with paramedics 
compared to non-paramedics. This finding suggests that prehospital medication 
ascertainment might be improved either by enhanced education and training and/or by 
attempting to increase the proportion of transfers for which a paramedic does the PCR 
documentation.
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Our results should be interpreted in the context of some limitations. First, this was a 
retrospective study and subject to the inherent limitations of using retrospective data.39 
Second, ED and hospital documentation of medication use as the reference standard may be 
problematic. ED and hospital medication ascertainment may also be subject to the same 
limitations as prehospital medication ascertainment (e.g., patients who are poor historians or 
acutely injured). However, we conducted a sensitivity analysis using an elevated INR as the 
reference standard for patients on warfarin and found similar agreement measurements. 
Third, data is provided only on documented use of anticoagulants and antiplatelets. It is 
possible that EMS providers knew that a patient was taking a particular anticoagulant or 
antiplatelet medication and verbalized this to ED staff, however did not document it on 
medical records. Finally, the results of this study are based on data primarily from one 
county and may not be generalizable to other EMS systems. However, we included EMS 
agencies and hospitals that differed by volume of transports and trauma center designation 
and thus represents a heterogeneous EMS system.
CONCLUSIONS
The use of antiplatelet or anticoagulant medications in older adults with blunt head trauma 
and transported by EMS is common. EMS and ED/hospital providers have acceptable 
agreement with when assessing for a patient’s use of warfarin but not with DOAC, aspirin, 
and other antiplatelet agent use.
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Agreement stratified by EMS agency and medication
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Figure 2. Agreement stratified by level of transport and provider level
Panel A. Agreement stratified by level of transport
Panel B. Agreement stratified by provider level
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Age, median (interquartile range) 73 (62–85)
Male sex 1259 (60)
Race
• White 1403 (66)
• Black 172 (8)
• Asian 182 (9)
• American Indian/Alaskan Native 11 (0.52)
• Pacific Islander/Native Hawaiian 27 (1.3)
• Other 169 (8)
• Not reported 205 (10)
Hispanic 141 (6.7)
Initial prehospital Glasgow Coma Scale score of 15 a 1638 (81)
Mechanism of injury
• Direct blow to head 107 (5)
• Fall from greater than standing height 81 (4)
• Fall from standing height or less 1445 (68)
• Motor vehicle collision >35 miles per hour 117 (6)
• Motor vehicle collision ≤35 miles per hour 186 (9)
• Auto vs. pedestrian/bicyclist 58 (3)
• Other mechanism of injury 57 (3)
• Unknown mechanism 59 (3)
Pre-hospital intubation or use of bag valve mask device 4 (0.2)
Reported dementia 254 (12)
Reported intoxication 213 (10)
Primary language is not English 129 (6.1)
• If language was not English, prehospital provider was able to obtain an medication history 76 (58.9)
 ➢ Using some English 31 (41)
 ➢ Translated 41 (54)
 ➢ Other means 4 (5)
*
missing GCS scores in 61 patients













Nishijima et al. Page 14
Table 2
EMS Provider Characteristics, n=2110 transports
Characteristic n (%)
EMS Agency
• Agency 1 278 (13)
• Agency 2 150 (7)
• Agency 3 104 (5)
• Agency 4 952 (45)
• Agency 5 626 (30)
Advance Life Support transport 1199 (57)
EMS provider was paramedic 1567 (74)
Abbreviations: EMS, Emergency Medical Services
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